C07K 14/46
From vertebrates
Official title: from vertebrates
C07K14/46 (From vertebrates) appears on 18,521 US grants and 28,194 published applications in this corpus.
Search patents in C07K- Granted patents
- 18,521
- Published applications
- 28,194
- Assignees
- 6,951
- Inventors
- 41,136
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 5 | 0 |
| 1979 | 8 | 0 |
| 1980 | 11 | 0 |
| 1981 | 12 | 0 |
| 1982 | 7 | 0 |
| 1983 | 7 | 0 |
| 1984 | 12 | 0 |
| 1985 | 14 | 0 |
| 1986 | 10 | 0 |
| 1987 | 14 | 0 |
| 1988 | 22 | 0 |
| 1989 | 28 | 0 |
| 1990 | 28 | 0 |
| 1991 | 39 | 0 |
| 1992 | 63 | 0 |
| 1993 | 118 | 0 |
| 1994 | 123 | 0 |
| 1995 | 135 | 0 |
| 1996 | 232 | 0 |
| 1997 | 411 | 0 |
| 1998 | 739 | 0 |
| 1999 | 751 | 0 |
| 2000 | 623 | 0 |
| 2001 | 673 | 121 |
| 2002 | 610 | 1404 |
| 2003 | 598 | 3546 |
| 2004 | 540 | 1522 |
| 2005 | 487 | 1399 |
| 2006 | 703 | 1174 |
| 2007 | 775 | 961 |
| 2008 | 692 | 859 |
| 2009 | 549 | 981 |
| 2010 | 601 | 903 |
| 2011 | 578 | 851 |
| 2012 | 450 | 722 |
| 2013 | 515 | 736 |
| 2014 | 462 | 844 |
| 2015 | 522 | 836 |
| 2016 | 556 | 915 |
| 2017 | 563 | 809 |
| 2018 | 563 | 946 |
| 2019 | 635 | 1022 |
| 2020 | 655 | 1085 |
| 2021 | 686 | 1150 |
| 2022 | 639 | 1232 |
| 2023 | 502 | 1141 |
| 2024 | 612 | 1238 |
| 2025 | 577 | 1064 |
| 2026 | 359 | 733 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Microdystrophin nucleic acid gene therapy constructs and uses thereof6 Oct 2026US 12,752,020 B2REGENXBIO Inc.
- Methods of manufacturing microdystrophin gene therapy constructs6 Oct 2026US 12,752,021 B2REGENXBIO Inc.
- Protein with anti-inflammatory properties6 Oct 2026US 12,753,214 B2Revolo Biotherapeutics Limited
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Bioactive agents and methods related thereto6 Oct 2026US 12,753,216 B2Aroa Biosurgery Limited
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Influenza estem immunogens8 Oct 2026US 2026/0306612 A1
- Chimeric receptors8 Oct 2026US 2026/0306631 A1St. Jude Children?S Research Hospital
- Polymer-based therapeutics for inductive browning of fat8 Oct 2026US 2026/0306643 A1Purdue Research Foundation
Most cited
By later US patents
- Humanised antibodies1,093US 5,859,205 ACelltech Limited · 1999
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003
- Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites556US 6,453,242 B1Sangamo BioSciences, Inc. · 2002
- Humanized antibodies528US 6,632,927 B2Celltech Therapeutics Limited · 2003
- Isolation of exogenous recombinant proteins from the milk of transgenic mammals500US 4,873,316 ABiogen, Inc. · 1989